Sodium-glucose cotransporter-2 inhibitor-associated erythrocytosis: A retrospective cohort study

被引：1
|
作者：
Liu, Jessica [1 ]
Chin-Yee, Benjamin [2 ]
Chin-Yee, Ian H. [2 ,3 ]
Ho, Jenny [2 ]
Sadikovic, Bekim [3 ]
Hsia, Cyrus C. [2 ,4 ]
机构：
[1] London Hlth Sci Ctr, Dept Med, London, ON, Canada
[2] London Hlth Sci Ctr, Dept Med, Div Hematol, London, ON, Canada
[3] London Hlth Sci Ctr, Dept Pathol & Lab Med, London, ON, Canada
[4] Victoria Hosp, Room E6 219A,800 Commissioners Rd, London, ON N6A5W9, Canada
来源：
JOURNAL OF INTERNAL MEDICINE | 2024年 / 295卷 / 01期
关键词：
D O I：
10.1111/joim.13722
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：103 / 105
页数：3
相关论文
共 50 条
  • [41] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Mckenzie, Taylor
    Hale, Genevieve M.
    Miner, Amelia
    Colon, Jean Colon
    Evins, Garrett
    Wade, Jasmine
    HEART FAILURE REVIEWS, 2024, 29 (02) : 549 - 558
  • [42] RE: Gout and sodium-glucose cotransporter-2 inhibitors
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 114 - 115
  • [43] Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review
    Sanjay Kalra
    Vikram Singh
    Dinesh Nagrale
    Advances in Therapy, 2016, 33 : 1502 - 1518
  • [44] Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports
    Khedr, Anwar
    Hennawi, Hussam Al
    Khan, Muhammed Khuzzaim
    Eissa, Aalaa
    Mir, Mikael
    Rauf, Ibtisam
    Nitesh, Jain
    Surani, Salim
    Khan, Syed Anjum
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (24) : 5700 - 5709
  • [45] Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report
    Seger, Christian D.
    Xing, Hanning
    Wang, Libing
    Shin, John S.
    A & A PRACTICE, 2021, 15 (01): : e01380
  • [46] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Taylor McKenzie
    Genevieve M. Hale
    Amelia Miner
    Jean Colón Colón
    Garrett Evins
    Jasmine Wade
    Heart Failure Reviews, 2024, 29 : 549 - 558
  • [47] Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2
    Chen, Sha
    Wang, Qian
    Christodoulou, Andriana
    Mylonas, Nikolaos
    Bakker, Diane
    Nederlof, Rianne
    Hollmann, Markus W.
    Weber, Nina C.
    Coronel, Ruben
    Wakker, Vincent
    Christoffels, Vincent M.
    Andreadou, Ioanna
    Zuurbier, Coert J.
    CIRCULATION, 2023, 147 (03) : 276 - 279
  • [48] Risk of hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Chang, Yoosoo
    Sinn, Dong Hyun
    Yu, Oriana Hoi Yun
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 7 - 8
  • [49] Sodium-Glucose Cotransporter 2 Inhibitor-Linked Pericolonoscopy Hyperketonemia: A Retrospective Study
    Thiruvenkatarajan, Venkatesan
    Smithson-Tomas, Georgia
    Jothin, Arvind
    Meyer, Emily
    Lindley, Brianna
    Jesudason, David
    Nanjappa, Nagesh
    Van Wijk, Roelof
    DIABETES CARE, 2022, 45 (05) : E91 - E92
  • [50] Risk of erythrocytosis associated with combined use of sodium-glucose cotransporter-2 inhibitors and testosterone replacement therapy in persons with type 2 diabetes
    Schumacher, K.
    Gemoets, D. E.
    Gosmanov, A. R.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S349 - S349
12345